Evaluation of the Effectiveness and Safety of Remote Electrocardiographic Monitoring in Patients with Atrial Fibrillation Following Ablation Therapy

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 270 participants.

Also called NCT06751459

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose supportive care
Phase
Not applicable
Enrolled
  • 270 participants (planned count) (from the registry)
Sponsor
HUINNO Co., Ltd (from the registry)
Registry
  • NCT NCT06751459
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06751459. Randomized; no masking; primary purpose supportive care. Start 2025-01-06 (anticipated); primary completion 2026-08-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of the Effectiveness and Safety of Remote Electrocardiographic Monitoring in Patients with Atrial Fibrillation Following Ablation Therapy
Acronym
PREEMPT-AF
Condition
Atrial Fibrillation (AF)
Intervention (Device)
MEMO Patch 2 - 14-day Monitoring
Intervention (Device)
MEMO Patch 2 - 1-day Monitoring
Intervention (Device)
MEMO Link
Lead sponsor
HUINNO Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct06751459
Content hash
2a5bc1e9f324d56fa6d002ce5c73e6f292933b1ff7031bf7a6169ed409c6dc6c